---
$id: https://graph.org.ai/products/commodity/51162709
$type: Product
source: UNSPSC
code: "51162709"
title: "Cistinexine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cistinexine

**UNSPSC Code**: 51162709
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent and expectorant with the molecular formula C50H60Br4N6O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 62VR67FK8E, chemically known as 2-oxa-7,8-dithia-4,11-diazadodecan-12-oic acid, 5,10-bis(((2,4-dibromo-6-((cyclohexylmethylamino)methyl)phenyl)amino)carbonyl)-3-oxo-1-phenyl-, phenylmethyl ester, (r-(r*,r*))- but more generally known as cistinexine, which bears US NIH Compound Identifier 65644. European Medicines Agency schedules Cistinexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07484MIG. The term CISTINEXINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 40, No. 6, 1986, List 26). CISTINEXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cistinexine under HS 29309016 and SITC 51549. As of Q4 2014, CISTINEXINE remains US FDA's Preferred Term for this commodity. Cistinexine bears US NLM identifiers UMLS ID C0627299 and NCI Concept Code C77595. SMILES: BRC1C(NC(=O)C(NC(=O)OCC2CCCCC2)CSSCC(NC(=O)OCC2CCCCC2)C(=O)NC2C(CN(C3CCCCC3)C)CC(BR)CC2BR)C(CN(C2CCCCC2)C)CC(BR)C1.

